The average age of men who get diagnosed is 67.

Dr. Ali Kasraeian from Kasraeian Urology is the first in our area to utilize a new minimally invasive treatment, called Focal Therapy, that precisely targets and destroys prostate cancer tumors.

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

A retired Winnipeg teacher who raised money for his own prostate cancer treatment after learning that provincial health ...

MyMichigan Medical Center Sault has begun offering PSMA PET scans, providing men in the eastern Upper Peninsula with an advanced imaging tool to detect prostate cancer.

Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...